|
1
|
Karam F, Sayadi M, Dadi S, Sarab GA. Overexpression of miR-192 in fibroblasts accelerates wound healing in diabetic rats: research article. Eur J Med Res 2025; 30:239. [PMID: 40186269 PMCID: PMC11969854 DOI: 10.1186/s40001-025-02449-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2024] [Accepted: 03/10/2025] [Indexed: 04/07/2025] Open
Abstract
BACKGROUND Diabetic foot ulcer (DFU) is a severe diabetic complication. Transplantation of skin substitutes, stem cells, and platelet-rich plasma (PRP) treatments are promising tools to promote ulcer healing in diabetes. An important aspect of the remodeling phase of wound healing is collagen deposition. miR-192 increases the expression of COL1A2 by specifically targeting Smad-interacting protein 1 (SIP1). This study was designed to investigate the impact of combined treatment with platelet-rich plasma and fibroblast cells expressing miR-192 on the healing process of wounds using an experimental diabetic animal model. METHODS After transfection of HDF cells and induction of increased miR-192 expression, relative changes in COL1A2 gene expression were determined by the RT-PCR method. Rats were randomly divided into 6 groups: non-diabetic control group, diabetic control, backbone, PRP, miR-192, and PRP + miR-192 groups. Diabetes was induced in male Wistar rats of all treated groups except non-diabetic control through a 21-day high-fat diet and an intraperitoneal injection of 40 mg/kg streptozotocin. A 10-mm skin biopsy punch was used to create two full-thickness wounds on the dorsal part of the upper body in all six groups of animals. Hematoxylin-eosin and Mason's trichrome staining were used to evaluate the wounds and analyze histological changes. RESULTS The overexpression of miR-192 in HDF cells resulted in a significant increase in COL1A2 gene expression, which was 15.77-fold higher than the control group. PRP and pLenti-III-miR-192-GFP-expressing cells significantly increased wound closure rates, granulation tissue area, and collagen fiber density in rats, according to a histological examination. CONCLUSION The combined use of PRP and HDFs expressing pLenti-III-miR-192-GFP speeds up the healing of wounds by increasing collagen expression, demonstrating the efficacy of this approach in improving wound healing results.
Collapse
Affiliation(s)
- Forouzan Karam
- Department of Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
| | - Mahtab Sayadi
- Department of Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
| | - Saeedeh Dadi
- Department of Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
| | - Gholamreza Anani Sarab
- Department of Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
| |
Collapse
|
|
2
|
Chen Y, Wu Y, Xiong F, Yu W, Wang T, Xiong J, Zhou L, Hu F, Ye X, Liang X. Construction of a Collagen-like Protein Based on Elastin-like Polypeptide Fusion and Evaluation of Its Performance in Promoting Wound Healing. Molecules 2023; 28:6773. [PMID: 37836616 PMCID: PMC10574607 DOI: 10.3390/molecules28196773] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2023] [Revised: 09/13/2023] [Accepted: 09/14/2023] [Indexed: 10/15/2023] Open
Abstract
In the healing of wounds, human-like collagen (hCol) is essential. However, collagen-based composite dressings have poor stability in vivo, which severely limits their current therapeutic potential. Based on the above, we have developed a recombinant fusion protein named hCol-ELP, which consists of hCol and an elastin-like peptide (ELP). Then, we examined the physicochemical and biological properties of hCol-ELP. The results indicated that the stability of the hCol-ELP fusion protein exhibited a more compact and homogeneous lamellar microstructure along with collagen properties, it was found to be significantly superior to the stability of free hCol. The compound hCol-ELP demonstrated a remarkable capacity to induce the proliferation and migration of mouse embryo fibroblast cells (NIH/3T3), as well as enhance collagen synthesis in human skin fibroblasts (HSF) when tested in vitro. In vivo, hCol-ELP demonstrated significant enhancements in healing rate and a reduction in the time required for scab removal, thereby exhibiting a scar-free healing effect. The findings provide a crucial theoretical foundation for the implementation of an hCol-ELP protein dressing in fields associated with the healing of traumatic injuries.
Collapse
Affiliation(s)
- Yingli Chen
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Yuanyuan Wu
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Fengmin Xiong
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Wei Yu
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Tingting Wang
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Jingjing Xiong
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Luping Zhou
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Fei Hu
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Xianlong Ye
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
| | - Xinmiao Liang
- Ganjiang Chinese Medicine Innovation Center, Nanchang 330100, China; (Y.C.); (Y.W.); (F.X.); (W.Y.); (T.W.); (J.X.); (L.Z.); (F.H.)
- Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Zhongshan Road 457, Dalian 116023, China
| |
Collapse
|
|
3
|
Alhazmi A, Aldairi AF, Alghamdi A, Alomery A, Mujalli A, Obaid AA, Farrash WF, Allahyani M, Halawani I, Aljuaid A, Alharbi SA, Almehmadi M, Alharbi MS, Khan AA, Jastaniah MA, Alghamdi A. Antibacterial Effects of Commiphora gileadensis Methanolic Extract on Wound Healing. Molecules 2022; 27:molecules27103320. [PMID: 35630797 PMCID: PMC9143547 DOI: 10.3390/molecules27103320] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2022] [Revised: 05/17/2022] [Accepted: 05/19/2022] [Indexed: 11/16/2022] Open
Abstract
Commiphora gileadensis (CG) is a small tree distributed throughout the Middle East. It was traditionally used in perfumes in countries in this area. In Saudi Arabia, it was used to treat wounds burns and as an antidote to scorpion stings. This study aimed to evaluate the antimicrobial activity and cutaneous wound healing efficiency of the CG extracts using microbiological tests, rate of wound contraction and histopathological changes. CG plant were extracted using the methanol extraction technique; then, the methanolic extract was characterized using liquid chromatography coupled with mass spectrometry (LC−MS). Afterwards, a six-millimetre (mm) excision wound was induced in 60 male Balb/c mice. Mice were classified into two classes; each class consisted of three groups of 10 mice. In the non-infected wound class, the group I was assigned as control and received normal saline. Group II received gentamicin treatment, and group III treated with CG-methanolic extract. In the Staphylococcus aureus-infected class, group IV received normal saline, and groups V and VI were treated with gentamicin and CG-methanolic extract, respectively. The colonization of infected wounds was determined using colony-forming units (CFUs), and the percentage of wound contraction was measured in all groups. Finally, the histopathologic semi-quantitative determination of wound healing was evaluated by inflammatory cell infiltration, the presence of collagen fibres and granulation tissue, and the grade of re-epithelization. Composition analysis of the methanolic extract confirmed the presence of a high amount of ceramide (69%) and, to a lesser extent, hexosylceramide (18%) and phosphatidylethanolamine (7%) of the total amount. Additionally, there was a statistically significant difference between the percentage of wound contraction in the CG-treated and control groups in both Staphylococcus aureus-infected and non-infected wounds (p < 0.01). The colonization of the infected wounds was lower in the group treated with CG than in the control group (p < 0.01). In both non-infected and infected wounds, the CG-treated group showed significant statistical differences in inflammatory cell infiltration, collagen fibres, re-epithelization and granulation tissue formation compared with the control group (p < 0.01). The CG extract possesses antibacterial and anti-inflammatory properties that induce wound healing.
Collapse
Affiliation(s)
- Ayman Alhazmi
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; (A.A.); (A.A.); (A.A.); (M.A.); (I.H.); (A.A.); (M.A.)
| | - Abdullah F. Aldairi
- Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al Abdeyah, P.O. Box 7607, Makkah 21961, Saudi Arabia; (A.M.); (A.A.O.); (W.F.F.); (A.A.K.)
- Correspondence:
| | - Ahmad Alghamdi
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; (A.A.); (A.A.); (A.A.); (M.A.); (I.H.); (A.A.); (M.A.)
| | - Anas Alomery
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; (A.A.); (A.A.); (A.A.); (M.A.); (I.H.); (A.A.); (M.A.)
| | - Abdulrahman Mujalli
- Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al Abdeyah, P.O. Box 7607, Makkah 21961, Saudi Arabia; (A.M.); (A.A.O.); (W.F.F.); (A.A.K.)
| | - Ahmad A. Obaid
- Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al Abdeyah, P.O. Box 7607, Makkah 21961, Saudi Arabia; (A.M.); (A.A.O.); (W.F.F.); (A.A.K.)
| | - Wesam F. Farrash
- Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al Abdeyah, P.O. Box 7607, Makkah 21961, Saudi Arabia; (A.M.); (A.A.O.); (W.F.F.); (A.A.K.)
| | - Mamdouh Allahyani
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; (A.A.); (A.A.); (A.A.); (M.A.); (I.H.); (A.A.); (M.A.)
| | - Ibrahim Halawani
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; (A.A.); (A.A.); (A.A.); (M.A.); (I.H.); (A.A.); (M.A.)
| | - Abdulelah Aljuaid
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; (A.A.); (A.A.); (A.A.); (M.A.); (I.H.); (A.A.); (M.A.)
| | - Sarah A. Alharbi
- Laboratory Department, Prince Mohammed Bin Abdulaziz Hospital, Ministry of National Guard-Health Affairs, Al Madinah 41511, Saudi Arabia;
| | - Mazen Almehmadi
- Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; (A.A.); (A.A.); (A.A.); (M.A.); (I.H.); (A.A.); (M.A.)
| | - Moodi S. Alharbi
- Diabetic Centre, King Abdulaziz Speciality Hospital, Ministry of Health, Qurwa, Taif 26521, Saudi Arabia;
| | - Anmar A. Khan
- Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Al Abdeyah, P.O. Box 7607, Makkah 21961, Saudi Arabia; (A.M.); (A.A.O.); (W.F.F.); (A.A.K.)
| | - Maisam A. Jastaniah
- Laboratory Department, King Faisal Hospital, Ministry of Health, Makkah 24236, Saudi Arabia;
| | | |
Collapse
|
|
4
|
Liu M, Tao J, Guo H, Tang L, Zhang G, Tang C, Zhou H, Wu Y, Ruan H, Loh XJ. Efficacy of Water-Soluble Pearl Powder Components Extracted by a CO 2 Supercritical Extraction System in Promoting Wound Healing. MATERIALS (BASEL, SWITZERLAND) 2021; 14:4458. [PMID: 34442981 PMCID: PMC8399097 DOI: 10.3390/ma14164458] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Revised: 07/28/2021] [Accepted: 07/30/2021] [Indexed: 12/04/2022]
Abstract
Pearl powder is a biologically active substance that is widely used in traditional medicine, skin repair and maintenance. The traditional industrial extraction processes of pearl powder are mainly based on water, acid or enzyme extraction methods, all of which have their own drawbacks. In this study, we propose a new extraction process for these active ingredients, specifically, water-soluble components of pearl powder extracted by a CO2 supercritical extraction system (SFE), followed by the extraction efficiency evaluation. A wound-healing activity was evaluated in vitro and in vivo. This demonstrated that the supercritical extraction technique showed high efficiency as measured by the total protein percentage. The extracts exhibited cell proliferation and migration-promoting activity, in addition to improving collagen formation and healing efficiency in vivo. In brief, this study proposes a novel extraction process for pearl powder, and the extracts were also explored for wound-healing bioactivity, demonstrating the potential in wound healing.
Collapse
Affiliation(s)
- Minting Liu
- Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China; (M.L.); (H.Z.); (Y.W.)
| | - Junjun Tao
- Zhejiang Fenix Health Science and Technology Co., Ltd., Zhuji 311800, China; (J.T.); (H.G.); (L.T.); (G.Z.); (C.T.)
| | - Hongchen Guo
- Zhejiang Fenix Health Science and Technology Co., Ltd., Zhuji 311800, China; (J.T.); (H.G.); (L.T.); (G.Z.); (C.T.)
| | - Liang Tang
- Zhejiang Fenix Health Science and Technology Co., Ltd., Zhuji 311800, China; (J.T.); (H.G.); (L.T.); (G.Z.); (C.T.)
| | - Guorui Zhang
- Zhejiang Fenix Health Science and Technology Co., Ltd., Zhuji 311800, China; (J.T.); (H.G.); (L.T.); (G.Z.); (C.T.)
| | - Changming Tang
- Zhejiang Fenix Health Science and Technology Co., Ltd., Zhuji 311800, China; (J.T.); (H.G.); (L.T.); (G.Z.); (C.T.)
| | - Hu Zhou
- Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China; (M.L.); (H.Z.); (Y.W.)
| | - Yunlong Wu
- Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China; (M.L.); (H.Z.); (Y.W.)
| | - Huajun Ruan
- Zhejiang Fenix Health Science and Technology Co., Ltd., Zhuji 311800, China; (J.T.); (H.G.); (L.T.); (G.Z.); (C.T.)
| | - Xian Jun Loh
- Institute of Materials Research and Engineering, Agency for Science, Technology and Research, 2 Fusionopolis Way, Singapore 138634, Singapore
| |
Collapse
|
|
5
|
Wang S, Yang J, Zhao G, Liu R, Du Y, Cai Z, Luan J, Shen Y, Chen B. Current applications of platelet gels in wound healing-A review. Wound Repair Regen 2021; 29:370-379. [PMID: 33749992 DOI: 10.1111/wrr.12896] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2019] [Revised: 12/27/2020] [Accepted: 01/13/2021] [Indexed: 12/21/2022]
Abstract
Human platelets play important roles in several physiologic and pathologic processes. Platelet concentrates are activated with thrombin or calcium, resulting in a viscous coagulum (platelet gel [PG]), composed of 95% platelets at least. PG is increasingly used for the treatment of a variety of soft and hard tissue defects, most notably in the management of chronic non-healing wounds. During wound healing, platelets not only play a critical role in primary hemostasis and thrombosis, but also release growth factors and cytokines to promote tissue regeneration, enhance collagen synthesis, and trigger an immune response. This review addresses a variety of aspects relevant to the functions of well-known platelet growth factors, animal and clinical studies of PG in the last decade, and different sources of platelets for PG. PG is used for non-healing chronic wounds, such as oral ulcerations related to epidermolysis bullosa and chronic graft-versus-host disease, for those, the traditional treatment effect is poor. PG maybe provide a new therapeutic direction for these diseases. Nevertheless, some uncertainty is present, the number of clinical studies is not enough. Hence, randomized controlled trials are still required to study the potential of the use of PG in the near future.
Collapse
Affiliation(s)
- Shujun Wang
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.,School of Medicine, Southeast University, Nanjing, China.,Jinling Hospital Department Blood Transfusion, Nanjing University, School Medicine, Nanjing, China
| | - Jie Yang
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.,School of Medicine, Southeast University, Nanjing, China
| | - Guangchao Zhao
- Jinling Hospital Department Blood Transfusion, Nanjing University, School Medicine, Nanjing, China
| | - Ran Liu
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China
| | - Ying Du
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.,School of Medicine, Southeast University, Nanjing, China
| | - Zhimei Cai
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.,School of Medicine, Southeast University, Nanjing, China
| | - Jianfeng Luan
- Jinling Hospital Department Blood Transfusion, Nanjing University, School Medicine, Nanjing, China
| | - Yanfei Shen
- School of Medicine, Southeast University, Nanjing, China
| | - Baoan Chen
- Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China
| |
Collapse
|